Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v6-FR
Language French French
Date Updated 2020-03-26 2019-12-05
Drug Identification Number 00452130 00452130
Brand name NOVAMOXIN NOVAMOXIN
Common or Proper name AMOXICILLIN SUSP 250MG/5ML AMOXICILLIN SUSP 250MG/5ML
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients AMOXICILLIN AMOXICILLIN
Strength(s) 250MG 250MG
Dosage form(s) GRANULES FOR SUSPENSION GRANULES FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 150ml 150ml
ATC code J01CA J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-02 2019-10-02
Estimated end date 2020-03-31 2020-05-31
Actual end date 2020-03-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Coverage of Teva market out to end of 2019. Amoxicillin Low Sucrose (DIN 01934163 )is available in 100ml and 150ml as a substitution.
Health Canada comments